Scarica l'app Stockscreener
28.97
1.26%
0.35
Dopo l'orario di chiusura:
28.96
-0.010
-0.03%
Immunocore Holdings Plc Adr Borsa (IMCR) Ultime notizie
INDV Stock: What Sublocade Growth Signals for 2026 - TradingView
GSK's Momelotinib Gets Orphan Tag for Rare Hemato-Inflammatory Disorder - TradingView
Puma Biotechnology Stock Rises 19% in 3 Months: Here's Why - TradingView
HROW Stock Rises on Relaunch of Ophthalmology Drug Verkazia in the US - TradingView
Sanofi Ends Late-Stage Study on Neurology Drug Over Weak Results - TradingView
ALVO Stock Gains 19% on FDA Resubmission of Biosimilar BLAs - TradingView
RZLT Stock on the Move: What Sparks the 38% Jump in the Past Week? - TradingView
Kodiak Stock Rises 35% in 3 Months: Here's What You Need to Know - TradingView
ADCT Stock Plunges on Safety Concerns Despite Positive Lymphoma Data - TradingView
Amgen Secures EU Nod for Imdylltra in Lung Cancer Indication - TradingView
MRNA Partners With CEPI to Develop Vaccine for Bundibugyo Ebolavirus - TradingView
IMCR Stock Price, Quote & Chart | IMMUNOCORE HOLDINGS PLC-ADR (NASDAQ:IMCR) - ChartMill
REPL Stock Soars on Plans of BLA Resubmission for Melanoma Combo Drug - TradingView
AGIO Halts Tebapivat Development in Myelodysplastic Syndromes - TradingView
Immunocore presents updated Phase 1 data of brenetafusp in patients with heavily pretreated advanced melanoma - GlobeNewswire Inc.
TGTX's Single-Dose Briumvi Hits Bioequivalence Goal in MS Study - TradingView
Dyne Therapeutics Stock Gains 4.5% After BLA Filing for DMD Therapy - TradingView
AGIO's Pyrukynd Gets Approval for Thalassemia in Europe - TradingView
Wall Street analysts think Immunocore (IMCR) could surge 111.53%: Read this before placing a bet - MSN
69,271 ADRs sale scheduled by Immunocore (NASDAQ: IMCR) - Stock Titan
Here's Why You Should Add Altimmune Stock to Your Portfolio Now - TradingView
Wall Street Analysts Think Immunocore (IMCR) Could Surge 111.53%: Read This Before Placing a Bet - Yahoo Finance
Immunocore Holdings (NASDAQ: IMCR) plans 65,000 ADR cashless sale - Stock Titan
Dyne Stock Gains 10% on Initiation of Late-Stage Study in DMD Patients - TradingView
Is it a Good Idea to Invest in Stoke Therapeutics Stock Now? - TradingView
ATRA Stock Shoots Up 82% in a Month: Here's What You Should Know - TradingView
ERNA Stock Shoots Up 140% in a Month: Here's What You Should Know - TradingView
BMRN Stock Down on Mixed Results From Rare Disease Therapy Study - TradingView
FDA Accepts Viatris' NDA for Fast-Acting Non-Opioid Pain Therapy - TradingView
Bayer Gets FDA Priority Review for Asundexian NDA in Stroke Prevention - TradingView
Roche's Tecentriq Wins FDA Nod for Label Expansion in Bladder Cancer - TradingView
CRMD Q1 Earnings Beat on DefenCath Momentum, Guidance Raised - TradingView
T. Rowe Price (IMCR) holds 1.89M ADRs, files Schedule 13G/A amendment - Stock Titan
Immunocore Holdings stock (GB00BL963Z95): Recent price dip amid biotech trends - AD HOC NEWS
Catalyst Pharmaceuticals Q1 Earnings Beat, Firdapse Revenues Rise Y/Y - TradingView
Mizuho cuts Immunocore stock price target to $34 on trimmed revenue - Investing.com
IMCR SEC FilingsImmunocore Holdings Plc 10-K, 10-Q, 8-K Forms - Stock Titan
Hussman Strategic Advisors Inc. Purchases Shares of 42,000 Immunocore Holdings PLC Sponsored ADR $IMCR - MarketBeat
Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Immunocore (IMCR) upgraded to strong buy: Here's why - MSN
Q1 Earnings Forecast for Immunocore Issued By HC Wainwright - MarketBeat
Massachusetts Financial Services Co. MA Trims Holdings in Immunocore Holdings PLC Sponsored ADR $IMCR - MarketBeat
Immunocore (NASDAQ: IMCR) outlines 10 resolutions for 2026 hybrid AGM - Stock Titan
H.C. Wainwright reiterates Immunocore stock rating citing KIMMTRAK penetration - Investing.com
Immunocore Details KIMMTRAK Growth, TCR Platform and Key Readouts at Needham Conference - Yahoo Finance
Immunocore Holdings Plc (NASDAQ: IMCR) plans same‑day cashless sale of 25,000 ADRs - Stock Titan
Immunocore Holdings stock: What you need to know for smart investing now - AD HOC NEWS
Immunocore Holdings plc (IMCR) stock price, news, quote and history - uk.finance.yahoo.com
Immunocore Holdings stock: Precision Oncology Leader with ImmTAC Innovation - AD HOC NEWS
Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) Short Interest Down 15.4% in March - MarketBeat
Jefferies reiterates Hold on Immunocore stock amid competitor data By Investing.com - Investing.com South Africa
Jefferies reiterates Hold on Immunocore stock amid competitor data - Investing.com
1.23%
0.89%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):